Best Peptide for Weight Loss
GLP-1 class peptides have redefined what weight loss medicine can achieve. We compare the top four options — from the proven Semaglutide to the triple-agonist Retatrutide — with clinical data, dosing protocols, and a decision guide to find your best fit.
24.2%
Max clinical weight loss
4
Compounds compared
Tirze.
Best overall pick
Phase 3
Gold standard data
Our Pick: Tirzepatide
Tirzepatide
Best OverallThe only dual GLP-1 + GIP agonist with Phase 3 data showing 22.5% average weight loss — superior to Semaglutide in head-to-head trials. The best balance of efficacy, evidence quality, and tolerability.
22.5%
avg. body weight lost (SURMOUNT-1)
Mechanism
GLP-1 + GIP dual agonist
Dose Range
5–15mg/week SQ
Key Trial
SURMOUNT-1 (N=2,539)
All Weight Loss Peptides Compared
Semaglutide
Entry-Level14.9%
avg. weight loss (STEP 1 (N=1961))
Proven Phase 3 data
Weekly injection
Most clinical experience
Lowest side effect profile
Best for
GLP-1 newcomers, tolerability concerns
Tirzepatide
Best Overall22.5%
avg. weight loss (SURMOUNT-1 (N=2539))
Dual GLP-1 + GIP mechanism
22.5% average weight loss
Phase 3 proven
Superior to semaglutide head-to-head
Best for
Most people seeking proven, maximum-value weight loss
Retatrutide
Maximum Efficacy24.2%
avg. weight loss (Phase 2 (N=338))
Highest recorded weight loss
Triple receptor mechanism
Added metabolic benefits
Best for
Maximum results, comfortable with cutting-edge compounds
Cagrilintide + Semaglutide
Appetite + Amylin~25%
avg. weight loss (REDEFINE 1 (Phase 3, ongoing))
Amylin pathway (novel mechanism)
Additive to GLP-1
Strong appetite suppression
Best for
Plateau breakers and those who want next-generation approach
Which Weight Loss Peptide Is Right for You?
Choose Semaglutide if...
You want the most clinical long-term data
You're sensitive to GI side effects
You prefer a single, lower-cost compound
You are new to GLP-1 therapy
Choose Tirzepatide if...
You want the best-proven weight loss outcome
You've tried Semaglutide without enough response
You want dual-mechanism superiority
You want Phase 3-backed results
Choose Retatrutide if...
You want maximum possible weight loss
You've plateaued on dual-agonist therapy
You are comfortable with Phase 2 (early) data
Metabolic co-benefits (glucose, lipids) are a priority
Frequently Asked Questions
How much weight can I lose with GLP-1 peptides?
Clinical trial averages: Semaglutide 14.9% body weight, Tirzepatide 22.5%, Retatrutide 24.2%. Individual results range widely. A 200 lb person on Tirzepatide can expect to lose 35–50 lbs over 72 weeks with diet modification. Results plateau without caloric deficit — these peptides work by suppressing appetite, not burning fat directly.
What's the difference between Semaglutide and Tirzepatide?
Semaglutide is a GLP-1 receptor agonist — it mimics the gut hormone GLP-1 to suppress appetite and slow gastric emptying. Tirzepatide adds GIP (glucose-dependent insulinotropic polypeptide) receptor agonism, giving it a dual mechanism that produces superior weight loss. Head-to-head trials (SURMOUNT-5) confirm Tirzepatide outperforms Semaglutide at comparable doses. The tradeoff is typically higher GI side effects with Tirzepatide, especially during titration.
Do I need to exercise with weight loss peptides?
Exercise is not required for weight loss on GLP-1 peptides, but it is strongly recommended. The primary concern is lean mass preservation — GLP-1 peptides cause significant muscle loss alongside fat loss (approximately 30–40% of lost weight can be lean mass without resistance training). Adding strength training to a GLP-1 protocol preserves muscle, improves metabolic rate, and produces superior long-term body composition outcomes.
How long do I take GLP-1 peptides?
GLP-1 peptides are not a finite course — they are chronic medications. Weight regain after discontinuation is well-documented (average 2/3 of lost weight regained within 12 months). Most people use them for 12–24 months minimum, then consider maintenance dosing or cycling. Some individuals choose indefinite use. The decision should be based on reaching goal weight, metabolic health markers, and long-term sustainability.
Ready to Start Your Protocol?
Browse our full GLP-1 comparison for deep-dive dosing protocols, side effect management, and compound sourcing.
Related Reading